Tandem expands Libre 3 Plus compatibility
By HME News Staff
Updated 12:20 PM CDT, Wed July 1, 2026
SAN DIEGO – Tandem Diabetes Care has announced that its t:slim X2 insulin pump with Control-IQ+ automated insulin delivery technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor in five countries. The launch expands CGM choice for t:slim X2 pump users in the United Kingdom, Switzerland, Sweden, Finland and Italy. Tandem expects to add additional countries in 2026, including Belgium, the Netherlands and Germany. “People using AID want flexibility in the devices they use,” said Jordan Pinsker, MD, chief medical officer. “The addition of Abbott’s latest generation sensor expands CGM choice for people using our Control-IQ+ technology.” The FreeStyle Libre 3 Plus sensor can be worn for up to 15 days and sends glucose readings to the pump every minute. This data is also available on the Tandem t mobile app. The t:slim X2 insulin pump is powered by Control-IQ+ technology, which adjusts insulin every five minutes based on predicted glucose values. Control-IQ+ also includes Tandem’s AutoBolus feature, which calculates and delivers a correction bolus to help with missed meal boluses.
Comments